Overview

Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Poor responders to ovarian stimulation represents one of the most frustrating problems in reproductive medicine. The investigators hypothesize that ovarian response of those patients could improve by treating these patients with 25 mg DHEA tid for 12 weeks prior to stimulation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Athens
Collaborator:
Lito Maternity Hospital
Treatments:
Dehydroepiandrosterone
Menotropins